Comparison between silodosin and tamsulosin for medical expulsive therapy of lower ureteric stones

Comparison between silodosin and tamsulosin for medical expulsive therapy of distal ureteric calculus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029244

Enrollment

Registered

2020-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N219- Calculus of lower urinary tract, unspecified

Interventions

Intervention1: Medical therapy: One group of patients are given tablet silodosin 8mg HS OD for 2 weeks as medical expulsive therapy Control Intervention1: Medical therapy: One group of patients are gi

Eligibility

Inclusion criteria

Inclusion criteria: All patients with lower ureteric stone less than 10mm are included

Exclusion criteria

Exclusion criteria: Bilateral renal or ureteric stone and patient with sepsis are excluded

Design outcomes

Primary

Measure	Time frame
Passage of stone within 2 weeksTimepoint: Passage of stone within 2 weeks	—

Secondary

Measure	Time frame
Patient not passing stone till 2weeks of therapyTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactAtif Abdullah C

Chengalpattu Medical college

dr.gramesh77@gmail.com8489972828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026